A shares are welcome again, and they are released heavily! Retail investors: Are you going? Is it staying?The action plan can be called a heavy release in Shanghai, and I will simply classify the main contents.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.
It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.From the above four points of view, I think I will stay. As long as the upward trend of A shares is still there, I will not leave easily, so I can grasp the rhythm of high selling and low sucking.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.
Fourth, other fields also involve industrial chains such as electronic information generation, a new generation of intelligent networked vehicles and new energy vehicles, and also mention accelerating the merger of securities companies.It is worth noting that the action plan ranks biomedicine in the second place, and sets up a 10 billion biomedical industry M&A fund, which is basically the same as the status of integrated circuits. In addition, the action plan puts the merger of securities companies at the end, and its status has declined.
Strategy guide 12-13
Strategy guide 12-13